AKT1 and urinary bladder cancer: These results suggested that both the HT-1376 and 5637 bladder cancer cells responded to cetuximab-mediated cell killing via the inhibition of AKT and ERK phosphorylation, and that mCRPs were involved in this process (Supplementary Information 1).